SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation
CRSP 52.51+2.7%Nov 14 9:30 AM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: RMP who wrote (7885)2/20/2003 10:25:43 AM
From: Biomaven  Read Replies (2) of 52153
 
Ron,

I didn't listen to CEPH's call. Anyone who did know the reason for the light next quarter prediction?

CEPH has consistently beaten its guidance, and my guess is that this is more like a blip than anything else.

The stock is certainly not going to be a ten-bagger from here, but I think it will do fine from over the next few years. Growing earnings and little regulatory risk. The major uncertainty for me is the strength of their patent position on Provigil.

Peter
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News